KANK1 and neoplasm: Immunostaining of tumor sections from human breast cancer patients revealed that the majority of tumor cells contained KANK1 at cell-cell junctions and TAZ in the nucleus, and those LECs still attached to the BMs contained KANK1 at their basal, BM-binding side and TAZ diffusely in the cytoplasm.